Integer Holdings Sales Up 8.9%, Net Income Dips on Debt Costs, Acquisitions

TL;DR

**ITGR's sales growth is strong, but the massive hit to net income from debt costs and acquisitions makes it a 'wait and see' for profitability.**

AI Summary

Integer Holdings Corp (ITGR) reported robust financial performance for the nine months ended September 26, 2025, with sales increasing to $1,381.6 million from $1,267.1 million in the prior year, representing an 8.9% growth. Gross profit also rose to $375.6 million from $342.2 million. However, net income decreased significantly to $54.2 million from $87.2 million, primarily due to a substantial 'Other loss, net' of $53.0 million in 2025, compared to $1.8 million in 2024, and a debt conversion inducement expense of $46.7 million. The company actively pursued strategic acquisitions, including Precision Coating LLC for $153.5 million and VSi Parylene for $24.0 million, funded partly by its Revolving Credit Facility and the issuance of common stock. Long-term debt increased to $1,193.8 million from $980.2 million at December 31, 2024, reflecting these financing activities. Cash and cash equivalents increased to $58.9 million from $46.5 million, despite significant cash outflows for acquisitions totaling $170.9 million. The company also issued $977.5 million in convertible notes and made principal payments of $657.7 million on long-term debt.

Why It Matters

Integer's strategic acquisitions of Precision Coating LLC and VSi Parylene signal a clear intent to expand its specialized service offerings in the competitive medical device contract manufacturing market, which could enhance its long-term competitive advantage. While sales growth is positive for investors, the significant drop in net income due to debt-related charges and other losses warrants close scrutiny, impacting profitability metrics. Employees at the acquired companies will see integration into a larger, publicly traded entity, potentially bringing new opportunities or changes. For customers, these acquisitions mean a broader range of in-house capabilities, potentially streamlining their supply chains and offering more comprehensive solutions. The broader market will observe how ITGR integrates these new capabilities and whether they translate into sustained market share gains against rivals.

Risk Assessment

Risk Level: medium — The company's long-term debt increased significantly to $1,193.8 million from $980.2 million, and it incurred a substantial 'Other loss, net' of $53.0 million and a debt conversion inducement expense of $46.7 million. These financial activities, while supporting growth, introduce higher leverage and one-time costs that impacted net income, indicating potential financial volatility.

Analyst Insight

Investors should monitor Integer Holdings Corp's upcoming earnings calls for detailed explanations of the 'Other loss, net' and the integration progress of its recent acquisitions. While sales growth is positive, the significant increase in debt and the impact on net income suggest a need for caution; consider holding existing positions rather than initiating new ones until profitability trends stabilize.

Financial Highlights

revenue

$1,381.6M

total Assets

$3,397.3M

total Debt

$1,193.8M

net Income

$54.2M

gross Margin

27.2%

cash Position

$58.9M

revenue Growth

+8.9%

Key Numbers

• $1,381.6M — Sales for nine months ended Sep 26, 2025 (Increased 8.9% from $1,267.1 million in 2024)
• $54.2M — Net income for nine months ended Sep 26, 2025 (Decreased significantly from $87.2 million in 2024)
• $53.0M — Other loss, net for nine months ended Sep 26, 2025 (Major contributor to net income decrease, up from $1.8 million in 2024)
• $46.7M — Debt conversion inducement expense for nine months ended Sep 26, 2025 (New expense impacting net income)
• $153.5M — Acquisition cost of Precision Coating LLC (Funded with borrowings under Revolving Credit Facility)
• $24.0M — Acquisition cost of VSi Parylene (Funded with borrowings under Revolving Credit Facility and common stock)
• $1,193.8M — Long-term debt as of Sep 26, 2025 (Increased from $980.2 million at Dec 31, 2024)
• $977.5M — Proceeds from issuance of convertible notes (Contributed to financing activities)
• $657.7M — Principal payments of long-term debt (Significant cash outflow from financing activities)
• $58.9M — Cash and cash equivalents as of Sep 26, 2025 (Increased from $46.5 million at Dec 31, 2024)

Key Players & Entities

• Integer Holdings Corp (company) — Registrant, medical device contract development and manufacturing organization
• Precision Coating LLC (company) — Acquired manufacturer of high value surface coating technology platforms
• VSi Parylene (company) — Acquired full-service provider of parylene coating solutions
• New York Stock Exchange (regulator) — Exchange where ITGR is listed
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for financial statements
• FASB (regulator) — Financial Accounting Standards Board
• Katahdin Industries, Inc. (company) — Former parent company of Precision Coating LLC
• Vertical Solutions, Inc. (company) — Former parent company of VSi Parylene
• Electrochem Solutions, Inc. (company) — Discontinued operations sold in 2024
• Bloomberg (company) — Financial news organization

FAQ

Risk Factors

• Increased Debt Levels [medium — financial]: Long-term debt has increased significantly from $980.2 million at December 31, 2024, to $1,193.8 million as of September 26, 2025. This increase is primarily due to strategic acquisitions and the issuance of convertible notes, which could heighten financial risk and interest expense.
• Impact of Other Losses and Expenses [high — financial]: The nine months ended September 26, 2025, experienced a substantial 'Other loss, net' of $53.0 million, a significant increase from $1.8 million in the prior year. Additionally, a $46.7 million debt conversion inducement expense impacted net income, highlighting potential volatility in non-operating financial results.
• Integration of Acquisitions [medium — operational]: Integer Holdings completed two strategic acquisitions: Precision Coating LLC for $153.5 million and VSi Parylene for $24.0 million. The successful integration of these businesses is critical for realizing expected synergies and achieving projected returns, posing an operational risk if not managed effectively.
• Competition in Medical Device Outsourcing [medium — market]: The company operates in the competitive medical device outsourcing market. While sales grew 8.9% to $1,381.6 million for the nine months ended September 26, 2025, sustained growth depends on innovation, market share gains, and managing pricing pressures from competitors.
• Compliance with Healthcare Regulations [high — regulatory]: As a manufacturer of medical device components, Integer Holdings is subject to stringent regulatory requirements from bodies like the FDA. Non-compliance or changes in regulations could lead to product recalls, fines, or disruptions in operations.

Industry Context

Integer Holdings operates within the highly competitive medical device outsourcing (MDO) sector. This industry is characterized by a strong demand for specialized manufacturing capabilities, stringent regulatory oversight (e.g., FDA), and a trend towards consolidation through strategic acquisitions. Companies in this space focus on providing end-to-end solutions, from component manufacturing to finished device assembly, requiring significant investment in technology, quality systems, and supply chain management.

Regulatory Implications

As a key supplier to the medical device industry, Integer Holdings faces significant regulatory scrutiny. Compliance with FDA regulations (e.g., Quality System Regulation) and international standards is paramount. Any lapses in quality control or manufacturing processes could lead to costly recalls, warning letters, or suspension of operations, directly impacting financial performance and market reputation.

What Investors Should Do

1. Monitor the integration and performance of Precision Coating LLC and VSi Parylene.
2. Analyze the drivers and sustainability of the 'Other loss, net'.
3. Evaluate the impact of increased leverage and convertible note issuance.
4. Assess the impact of R&D spending reduction.

Key Dates

• 2025-09-26: Nine months ended financial reporting date — Provides latest performance data, showing revenue growth but a significant net income decline due to specific charges.
• 2024-12-31: Year-end financial reporting date — Baseline for comparison of year-over-year changes in debt and cash position.
• 2025-09-27: Prior year nine months ended financial reporting date — Establishes the comparative period for the current nine-month results, highlighting revenue growth and net income decrease.

Glossary

Other loss, net

This line item typically includes various non-operating income or expense items that do not fit into standard categories like interest or taxes. It can encompass foreign currency fluctuations, gains/losses on asset sales, or other miscellaneous items. (A significant increase in 'Other loss, net' to $53.0 million in the nine months of 2025 was a primary driver of the decrease in net income compared to the prior year.)

Debt conversion inducement expense

An expense incurred by a company to encourage bondholders to convert their debt into equity. This can include cash payments or other incentives offered to facilitate the conversion. (This $46.7 million expense in the nine months of 2025 directly reduced net income, impacting profitability.)

Revolving Credit Facility

A type of credit facility that allows a company to borrow, repay, and re-borrow funds up to a certain limit over a specified period. It provides flexible access to capital. (Integer Holdings utilized its Revolving Credit Facility to help fund strategic acquisitions, indicating its use as a source of short-term financing.)

Convertible Notes

A type of bond or debt security that can be converted into a predetermined amount of the issuer's equity at certain times during the bond's life. (The company issued $977.5 million in convertible notes, a significant financing activity that impacts the company's capital structure and potential future equity dilution.)

Year-Over-Year Comparison

Compared to the prior year period, Integer Holdings Corp. has demonstrated strong top-line growth, with sales increasing by 8.9% to $1,381.6 million for the nine months ended September 26, 2025. However, profitability has been significantly impacted, with net income decreasing substantially from $87.2 million to $54.2 million. This decline is primarily attributed to a sharp rise in 'Other loss, net' to $53.0 million and a new $46.7 million debt conversion inducement expense. While cash reserves have improved to $58.9 million, the company has also taken on considerable new debt, increasing long-term debt to $1,193.8 million, reflecting its aggressive acquisition strategy.

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share ITGR New York Stock

Filing Documents

• itgr-20250926.htm (10-Q) — 1747KB
• a2025q3ex311.htm (EX-31.1) — 17KB
• a2025q3ex312.htm (EX-31.2) — 17KB
• a2025q3ex321.htm (EX-32.1) — 9KB
• itgr-20250926_g1.jpg (GRAPHIC) — 76KB
• 0001114483-25-000134.txt ( ) — 10953KB
• itgr-20250926.xsd (EX-101.SCH) — 64KB
• itgr-20250926_cal.xml (EX-101.CAL) — 92KB
• itgr-20250926_def.xml (EX-101.DEF) — 351KB
• itgr-20250926_lab.xml (EX-101.LAB) — 863KB
• itgr-20250926_pre.xml (EX-101.PRE) — 629KB
• itgr-20250926_htm.xml (XML) — 1987KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Financial Statements

ITEM 1. Financial Statements 3 Condensed Consolidated Balance Sheets (Unaudited) 3 Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) 4 Condensed Consolidated Statements of Cash Flows (Unaudited) 5 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) 6 Notes to Condensed Consolidated Financial Statements (Unaudited) 7

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 34

Quantitative and Qualitative Disclosures About Market Risk

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 49

Controls and Procedures

ITEM 4. Controls and Procedures 49

—OTHER INFORMATION

PART II—OTHER INFORMATION

Legal Proceedings

ITEM 1. Legal Proceedings 50

Risk Factors

ITEM 1A. Risk Factors 50

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 50

Other Information

ITEM 5. Other Information 50

Exhibits

ITEM 6. Exhibits 50

SIGNATURES

SIGNATURES 51 - 2 - Table of Contents

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS INTEGER HOLDINGS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands except share and per share data) September 26, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 58,944 $ 46,543 Accounts receivable, net of provision for credit losses of $ 0.5 million and $ 0.3 million, respectively 310,165 245,269 Inventories 263,538 247,126 Contract assets 107,106 103,772 Prepaid expenses and other current assets 38,369 28,409 Total current assets 778,122 671,119 Property, plant and equipment, net 517,003 465,798 Goodwill 1,098,818 1,017,729 Other intangible assets, net 837,698 778,286 Deferred income taxes 8,545 8,309 Operating lease assets 99,514 86,082 Financing lease assets 32,151 27,689 Other long-term assets 25,459 22,959 Total assets $ 3,397,310 $ 3,077,971 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current portion of long-term debt $ — $ 10,000 Accounts payable 110,744 101,498 Operating lease liabilities 9,125 7,352 Accrued expenses and other current liabilities 89,952 108,323 Total current liabilities 209,821 227,173 Long-term debt 1,193,826 980,153 Deferred income taxes 114,696 124,608 Operating lease liabilities 82,693 77,702 Financing lease liabilities 25,510 23,760 Other long-term liabilities 24,927 25,360 Total liabilities 1,651,473 1,458,756 Stockholders' equity: Common stock, $ 0.001 par value; 100,000,000 shares authorized; 35,475,146 and 33,546,262 shares issued, respectively; 35,038,156 and 33,546,256 shares outstanding, respectively 35 34 Additional paid-in capital 765,566 741,977 Treasury stock, at cost; 436,990 shares and 6 shares, respectively ( 26,858 ) — Retained earnings 945,447 891,247 Accumulated other comprehensive income (loss) 61,647 ( 14,043 ) Total stockholders' equity 1,745,837 1,619,215 Total liabilities and stockholders' equity $ 3,397,310 $ 3,077,971 The accompanying notes are an integral part of

View Full Filing

View this 10-Q filing on SEC EDGAR